ダウンロード数: 222

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
16_0231.pdf344.53 kBAdobe PDF見る/開く
タイトル: 前立腺肥大症に対するPPCの治験
その他のタイトル: Double blind test of PPC for prostatic hyperplasia
著者: 島谷, 政佑  KAKEN_name
杉浦, 弌  KAKEN_name
著者名の別形: Shimaya, Masasuke
Sugiura, Hajime
キーワード: Aged
Alanine/therapeutic use
Amino Acids/therapeutic use
Drug Synergism
Glutamates/therapeutic use
Humans
Male
Middle Aged
Prostatic Hyperplasia/drug therapy
発行日: May-1970
出版者: 京都大学医学部泌尿器科学教室
誌名: 泌尿器科紀要
巻: 16
号: 5
開始ページ: 231
終了ページ: 236
抄録: In our previous report, the clinical effect of PPC applied to prostatic diseases was described. In this paper, in order to estimate the clinical effectiveness of PPC, so-called double blind test was carried out by means of administration of three kinds of compound arranged at random. These compounds are as follows: PPC: L-glutamic acid, L-alanine, amino-acetic acid PA : L-glutamic acid, L-alanine PG : L-glutamic acid The clinical result was estimated by the statistic method, that is, Fisher's direct calculation of probability. The calculated values showed the significant difference between PPC group and the controls, which means that the clinical effect of PPC is precisely more excellent than those of PA and PG for the treatment of subjective symptoms associated with prostatic hyperplasia. However, satisfactory improvement was not observed on rectal palpation or x-ray examination in any case.
URI: http://hdl.handle.net/2433/121119
PubMed ID: 4194682
出現コレクション:Vol.16 No.5

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。